EQS-News: CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth
Mannheim, Germany, April 10, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Catherine Canales as Chief Commercial Officer (CCO), effective today, completing the new CRS leadership team.
- Mannheim, Germany, April 10, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Catherine Canales as Chief Commercial Officer (CCO), effective today, completing the new CRS leadership team.
- Together, they are committed to steering the company's strategic development, growth, and innovation on a global scale.
- Dr. Elisabeth Lackner, CEO of CRS, commented on the appointment: “It is a great pleasure to welcome Catherine on board the CRS management team.
- Before that, she served as Director, Business Development at Premier Research, driving business growth and sales by promoting phase I-IV clinical development services.